InsidersTradesSigma
Track the Parallax Health Sciences, INC. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Operating in the Technology sector, Parallax Health Sciences, INC. has logged 1 insider filings. Market capitalisation: €1,096.4bn. The latest transaction was reported on 17 March 2022 (J). Among the most active insiders: WITHROW EDWARD W III. All data is free.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Parallax Health Sciences, INC. Strong Buy (bullish), based on 42 analysts. Average price target: US$1,491.95.
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,846 of 29,064 companies
71.3
score / 100
Value64
Quality79
FCF yld1.2%
Earn yld6.4%
EV/EBITDA8.1x
ROE67%
Gross mgn40%
Net mgn23%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 March 2022
Declarations1 total
7,050,773 shares@ US$0.080.0001% mcap100.0% of flowCOMMON STOCKSEC:0001388410-22-000004:0
1 of 1 declaration
关于 Parallax Health Sciences, INC.
Parallax Health Sciences, INC. 是一家专注于开发创新健康解决方案的科技公司。该公司在 XNAS 市场上市。